Excited to share our new preprint on BioRxiv: “Novel compounds derived from AR-12 that demonstrate host-directed clearance of intracellular Salmonella enterica Serovar Typhimurium.”
Our work highlights a host-directed approach that disrupts the cellular pathways Salmonella exploits, offering a promising strategy to combat intracellular and drug-resistant infections.
If you’re interested in host-directed therapies, antibiotic resistance, or novel therapeutic strategies, check out the preprint on BioRxiv https://go.unc.edu/Salmonella2025Preprint or Substack https://go.unc.edu/Salmonella2025PreprintSubSt
